Michael Sørensen

FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Colorectal cancer is a common cancer in the Nordic countries and 50% of the patients develop liver metastases. Liver resection may result in long term survival. Proper staging is therefore essential and CT is the standard imaging modality. We examined whether additional FDG-PET improves therapeutic management of patients with colorectal liver metastases.
Original languageEnglish
JournalScandinavian Journal of Surgery
Pages (from-to)209-213
Number of pages5
Publication statusPublished - 2007

    Research areas

  • Adult, Aged, Colorectal Neoplasms, Diagnosis, Differential, Female, Fluorodeoxyglucose F18, Follow-Up Studies, Hepatectomy, Humans, Laparotomy, Liver Neoplasms, Male, Middle Aged, Positron-Emission Tomography, Prospective Studies, Radiopharmaceuticals, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 44390511